Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 would would +6.86%
#4 Hive Hive +6.25%
#5 WAX WAX +5.69%
#6 Pons Pons +4.94%
#7 The Bitcoin Bull The Bitcoin Bull +4.43%
#8 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#9 edgeX edgeX +3.72%
#10 Ribbita by Virtuals Ribbita by Virtuals +3.31%
Coin of the day
Palladium Network Palladium Network
설정
언어
한국어
통화
USD
테마
Atrys Health, S.A. Atrys Health, S.A.

Atrys Health, S.A.

ATRY
주식 순위 #17814
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in... Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
주가
$2.97
마지막 동기화: 2026-09-02
시가총액
$225.13M
변동 (1일)
-0.99%
변동 (1년)
-10.45%
국가
ES
거래 Atrys Health, S.A. (ATRY)

카테고리

Healthcare
Atrys Health, S.A. (ATRY)의 매출
Sep 2026 기준 매출 TTM: 0
Atrys Health, S.A.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Atrys Health, S.A.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH